EMA Authorised: Deferasirox Accord (deferasirox) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Deferasirox Accord (deferasirox) for treating iron overload and beta-thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Iron Overload

Drugs mentioned

• Deferasirox Accord (deferasirox)

Snippet

Status: Authorised. Therapeutic area: Iron Overload;beta-Thalassemia. MAH: Accord Healthcare S.L.U.. Decision date: 30/09/2025